ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.

Andres Wiernik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.